Migreen kliinilised uuringud osariigis Ohio
13 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Ohio.
Linnad osariigis Ohio
Ametlik uuringutekst (inglise keeles)
Study of EVO756 in Adults With Migraine
- NeuroScience Research Center, Canton
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
VärbamineFaas 1
Vanused 6–11 · Kõik sood · Uuendatud 28. sept 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 28. sept 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
Värbamine
Vanused 10–17 · Kõik sood · Uuendatud 21. sept 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 16. sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- ja veel 3
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 14. sept 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 12. juuni 2026 · NCT05987592A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center - PIN, Cincinnati
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 12. juuni 2026 · NCT05164172Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
VärbamineFaas 4
Vanused 6–11 · Kõik sood · Uuendatud 27. jaan 2025 · NCT04748601Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 10–19 · Kõik sood · Uuendatud 22. aug 2024 · NCT05752396Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.